1.19
0.00%
0.00
Atai Life Sciences N V (ATAI) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
100.00%
-
|
0.018 | 0.087 | 0.172 | 0.037 |
Operating Expenses |
28.27%
24.09
|
33.58 | 26.92 | 32.03 | 33.25 |
Interest Income/Expense |
0.58%
0.687
|
0.691 | 0.686 | 0.658 | 0.622 |
Operating Income/Loss |
28.24%
-24.09
|
-33.56 | -26.83 | -31.86 | -33.21 |
Nonoperating Income/Loss |
110.47%
-1.596
|
15.24 | 70.68 | 0.204 | 0.058 |
Income/Loss Before Equity Method Investments |
40.18%
-25.68
|
-18.32 | 43.85 | -31.66 | -33.16 |
Income/Loss From Equity Method Investments |
331.73%
-1.701
|
-0.394 | -0.238 | -1.928 | -1.033 |
Income/Loss From Continuing Operations Before Tax |
40.18%
-25.68
|
-18.32 | 43.85 | -31.66 | -33.16 |
Income Tax Expense/Benefit |
100.93%
-0.004
|
0.428 | 0.238 | 0.185 | 0.165 |
Income/Loss From Continuing Operations After Tax |
36.96%
-25.68
|
-18.75 | 43.61 | -31.84 | -33.32 |
Net Income/Loss
|
43.03%
-27.38
|
-19.14 | 43.37 | -33.77 | -34.35 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
21.76%
-0.665
|
-0.85 | -0.873 | -0.729 | -1.219 |
Basic Average Shares |
5,126%
158.89
|
3.0402 | 155.79 | 155.79 | 155.79 |
Diluted Average Shares |
5,126%
158.89
|
3.0402 | 177.57 | 155.79 | 155.79 |
Basic Earnings Per Share |
54.55%
-0.17
|
-0.11 | 0.28 | -0.21 | -0.21 |
Diluted Earnings Per Share |
54.55%
-0.17
|
-0.11 | 0.25 | -0.21 | -0.21 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):